Parham Academy LLC
European Academy of Biomedical Sciences


Our news & hot issues


ISI Impact factor= 5.49 (Q1)



Google Scholar :::: PubMed :::: ResearchGate

Kaboli, P.J., Ismail, P., and Ling, K.-H. (2017). Berberine Derivatives as Multi-Kinase Inhibitors of MAP Kinase and PI3K Pathways: Molecular Modelling, Molecular Dynamics Simulations, and in vitro Evaluation. FASEB J. 31: 671.12-671.12.
ISI Impact factor= 5.49 (Q1)

Kaboli, P.J.
, Bazrafkan, M., Ismail, P., and Ling, K.-H. (2017). A Novel One-Click Automated Drug Discovery tool: A New Approach Based on Binding Efficiency Indices. FASEB J. 31: 818.7-818.7.
ISI Impact factor= 5.49 (Q1)

Kaboli, P.J.
, Rahmat, A., Ismail, P., Ling, K.-H., 2015. MicroRNA-based therapy and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacological Research, doi:10.1016/j.phrs.2015.04.015.
ISI Impact factor= 4.82 (Q1) - PubMed - ScienceDirect
This article has been cited by 49 articles.

Mir, A., Sadegh, M.H., Ahmadinia, Z., Jabbarzadeh Kaboli, P.*, 2015. PIK3CA rs7640662 (C/G) single nucleotide polymorphism lacks association with breast cancer cases in Persians. Interventional Medicine and Applied Science, 7 (1), 3-8. doi:10.1556/IMAS.7.2015.1.1
PubMed
This article has been cited by 2 article.

Jabbarzadeh Kaboli, P., Rahmat, A., Ismail, P., Ling, K.-H., 2014. Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer. European Journal of Pharmacology, 740C, 584–595. doi:10.1016/j.ejphar.2014.06.025.
ISI Impact factor= 2.75 (Q2) - PubMed - ScienceDirect
This article has been cited by 49 articles.




Author watson Home 11:59:34 | | | printer friendly | | create pdf of this news item


Our article: Therapeutic miRNAs


 Pharmacological Research




Headlines





Date published: not known
Details

»Investigating flu vaccine effectiveness
»How lipopolysaccharides bridge the gap
»SNF'ing out antitumor immunity
»CRISPR-Cas accelerates phage evolution
»Recognizing danger signals
»It's a wrap
»Forming photonic bound states
»A way to prevent generalized seizures?
»Air pollution evolution
»Left- or right-handed C-H bond activation


Date published: not known
Details

»G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs? [Minireview-Axelrod Symposium 2017]
Estimates vary regarding the number of G protein-coupled receptors (GPCRs), the largest family of m ...
»Biased Agonism in Drug Discovery--Is It Too Soon to Choose a Path? [Minireview-Axelrod Symposium 2017]
A single receptor can activate multiple signaling pathways that have distinct or even opposite effe ...
»Is the Quest for Signaling Bias Worth the Effort? [Perspective-Axelrod Symposium 2017]
The question of whether signaling bias is a viable discovery strategy for drug therapy is discussed ...
»cAMP Signaling Compartmentation: Adenylyl Cyclases as Anchors of Dynamic Signaling Complexes [Minireview-Axelrod Symposium 2017]
It is widely accepted that cAMP signaling is compartmentalized within cells. However, our knowledge ...
»Caveolins as Regulators of Stress Adaptation [Minireview-Axelrod Symposium 2017]
Caveolins have been recognized over the past few decades as key regulators of cell physiology. They ...


Date published: not known
Details

»Exploiting the geometry of the solution space to reduce sensitivity to neuromotor noise
»The self-organization of plant microtubules inside the cell volume yields their cortical localization, stable alignment, and sensitivity to external cues
»Prediction of infectious disease epidemics via weighted density ensembles
»Control fast or control smart: When should invading pathogens be controlled?
»Metabolic enzyme cost explains variable trade-offs between microbial growth rate and yield
»Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents
»In silico analysis of antibiotic-induced Clostridium difficile infection: Remediation techniques and biological adaptations
»A stochastic and dynamical view of pluripotency in mouse embryonic stem cells
»Integrating linear optimization with structural modeling to increase HIV neutralization breadth
»A multiscale modelling approach to assess the impact of metabolic zonation and microperfusion on the hepatic carbohydrate metabolism
»Optimizing homeostatic cell renewal in hierarchical tissues
»A comprehensive and quantitative comparison of text-mining in 15 million full-text articles versus their corresponding abstracts


Date published: not known
Details


THE FOUNDER and CEO

Parham Jabbarzadeh Kaboli, PhD

Research scientist
in molecular medicine


Expert in:

Cell and molecular Biology
Modelling and drug discovery
Cancer signaling pathways

H-index= 3 (Google Scholar)
i10-index= 3
Overall ISI impact factor= 18.15
Overall citation= 110 (Google Scholar)

Memberships:

The American Society for Pharmacology and Experimental Therapeutics (ASPET)

American Association for Cancer Research (AACR)

European Association for Cancer Research (EACR)

American Association for Advancement of Science (AAAS)



CONTACT INFORMATION


Affiliation:
Department of Biomedical Science,
Faculty of Medicine and Health Sciences,
Universiti Putra Malaysia,
UPM Serdang 43400,
Selangor, Malaysia

E-Mail: parham@gromacs.net
Telegram: telegram.me/parhamacademy
Featured Publication





View the full list.
Archives

Welcome

Username:

Password:



[ ]







This site is powered by Parham Academy.
This site is powered by Parham Academy.
Render time: 0.1689 sec, 0.0571 of that for queries.